The substantial changes observed over this period, combined with continued improvement for patients who continued treatment once a month, are encouraging for future studies. The changes observed indicate the potential efficacy of microcurrent to delay degeneration and possibly improve age-related macular degeneration, both wet and dry. However, this study has no control arm, so results should be treated with caution. Randomized double-blind controlled studies are needed to determine long-term effects.
No takes yet. Share an insight, caveat, or question.
Chaikin et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: